| ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas EP Samartzis, A Noske, KJ Dedes, D Fink, P Imesch International journal of molecular sciences 14 (9), 18824-18849, 2013 | 198 | 2013 |
| Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer AM Schmidt, P Imesch, D Fink, H Egger Gynecologic oncology 125 (3), 604-609, 2012 | 169 | 2012 |
| Loss of ARID1A expression sensitizes cancer cells to PI3K-and AKT-inhibition EP Samartzis, K Gutsche, KJ Dedes, D Fink, M Stucki, P Imesch Oncotarget 5 (14), 5295, 2014 | 152 | 2014 |
| Fatigue–a symptom in endometriosis A Ramin-Wright, ASK Schwartz, K Geraedts, M Rauchfuss, MM Wölfler, ... Human reproduction 33 (8), 1459-1465, 2018 | 140 | 2018 |
| Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? EP Samartzis, N Samartzis, A Noske, A Fedier, R Caduff, KJ Dedes, ... Modern Pathology 25 (6), 885-892, 2012 | 115 | 2012 |
| Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro R Koppensteiner, EP Samartzis, A Noske, A von Teichman, I Dedes, ... PloS one 9 (6), e100041, 2014 | 94 | 2014 |
| The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model K Schwager, F Bootz, P Imesch, M Kaspar, E Trachsel, D Neri Human reproduction 26 (9), 2344-2352, 2011 | 85 | 2011 |
| Endometriosis, especially mild disease: a risk factor for miscarriages ASK Schwartz, MM Wölfler, V Mitter, M Rauchfuss, F Haeberlin, ... Fertility and sterility 108 (5), 806-814. e2, 2017 | 84 | 2017 |
| The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer EP Samartzis, A Noske, A Meisel, Z Varga, D Fink, P Imesch PloS one 9 (1), e83296, 2014 | 79 | 2014 |
| Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial KJ Dedes, TD Szucs, P Imesch, A Fedier, MK Fehr, D Fink Annals of oncology 18 (9), 1493-1499, 2007 | 73 | 2007 |
| Does endometriosis affect professional life? A matched case-control study in Switzerland, Germany and Austria ML Sperschneider, MP Hengartner, A Kohl-Schwartz, K Geraedts, ... BMJ open 9 (1), e019570, 2019 | 67 | 2019 |
| Satisfaction with medical support in women with endometriosis I Lukas, A Kohl-Schwartz, K Geraedts, M Rauchfuss, MM Wölfler, ... PloS one 13 (11), e0208023, 2018 | 61 | 2018 |
| Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia MK Fehr, M Baumann, M Mueller, D Fink, S Heinzl, P Imesch, K Dedes Journal of gynecologic oncology 24 (3), 236-241, 2013 | 59 | 2013 |
| Developmental potential of human oocytes matured in vitro followed by vitrification and activation P Imesch, D Scheiner, M Xie, D Fink, E Macas, R Dubey, B Imthurn Journal of Ovarian Research 6, 1-5, 2013 | 58 | 2013 |
| The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells A Fedier, KJ Dedes, P Imesch, AO Von Bueren, D Fink International journal of oncology 31 (3), 633-641, 2007 | 58 | 2007 |
| The ENZIAN score as a preoperative MRI-based classification instrument for deep infiltrating endometriosis L Burla, D Scheiner, EP Samartzis, S Seidel, M Eberhard, D Fink, A Boss, ... Archives of gynecology and obstetrics 300, 109-116, 2019 | 57 | 2019 |
| Maltreatment during childhood: a risk factor for the development of endometriosis? C Liebermann, AS Kohl Schwartz, T Charpidou, K Geraedts, M Rauchfuss, ... Human reproduction 33 (8), 1449-1458, 2018 | 56 | 2018 |
| The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in endometriosis EP Samartzis, A Noske, N Samartzis, D Fink, P Imesch Reproductive Sciences 20 (12), 1416-1422, 2013 | 56 | 2013 |
| Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin P Imesch, EP Samartzis, M Schneider, D Fink, A Fedier Fertility and sterility 95 (5), 1579-1583, 2011 | 56 | 2011 |
| Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells P Imesch, D Fink, A Fedier Fertility and sterility 94 (7), 2838-2842, 2010 | 54 | 2010 |
